A. Atan And M. M. Basar, "Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.," The Journal of urology , vol.162, no.5, pp.1706, 1999
Atan, A. And Basar, M. M. 1999. Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.. The Journal of urology , vol.162, no.5 , 1706.
Atan, A., & Basar, M. M., (1999). Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.. The Journal of urology , vol.162, no.5, 1706.
Atan, ALİ, And M M Basar. "Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.," The Journal of urology , vol.162, no.5, 1706, 1999
Atan, ALİ And Basar, M M. . "Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.." The Journal of urology , vol.162, no.5, pp.1706, 1999
Atan, A. And Basar, M. M. (1999) . "Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.." The Journal of urology , vol.162, no.5, p.1706.
@article{article, author={ALİ ATAN And author={M M Basar}, title={Re: Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.}, journal={The Journal of urology}, year=1999, pages={1706} }